CTS (NYSE:CTS) Stock

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.

News

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

COOP

CSTM

GOOG

MANH

MSFT

NAVI

SPOT

TNET

UMBF

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping over 200 points. Here is the list of some big stocks recording losses in the previous session.

Boeing, Seagate, Chipotle And Other Big Losers From Wednesday

Penny Stocks

ADXN

AGYS

ARBK

ARVN

CIFR

COSM

New Oriental Education & Technology Group

EMAN

ENPH

EPIX

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EQOS

FEMY

FNHC

FRGT

GOVX

HCTI

HYPR

LMAO

LYLT

MNSO

MRUS

NRGV

OCFT

REVB

RNAZ

SBET

SINT

SMTS

STRY

TCDA

TENB

THMO

TPHS

TSHA

USEA

VAPO

VENA

YMAB

CDIO

Gainers


	ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.


Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday

Intraday Update

BPTS

GRNT

Gainers


	ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.


Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday&#39;s Mid-Day Session

CTS Corp

CONVERGE TECH SLTN CORP by Converge Technology Solutions Corporation

Converge Technology Solutions Corp

Cognizant Technology Solutions Corporation - Class A Common Stock

Cognizant Technology Solutions Corp

Cartesi - United States Dollar

CytoSorbents Corp

Cactus Acquisition Corp 1 Ltd Units (1 Ord Share Class A & 1/2 War)

Cactus Acquisition Corp 1 Ltd

Cactus Acquisition Corp 1 Ltd Warrants(17/08/2028)

<p><strong>CTS</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) announced its Q4 earnings on Tuesday, February 4, 2025 at 08:00 AM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>CTS missed estimated earnings by -2.0%, reporting an EPS of $0.53 versus an estimate of $0.54.</p>
<p>Revenue was up $2.74 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>In the previous quarter, the company beat on EPS by $0.06, resulting in a 2.0% increase change in the share price the following day.</p>
<p>Here's a look at CTS's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.53</td>
<td>0.41</td>
<td>0.46</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.63</td>
<td>0.54</td>
<td>0.47</td>
<td>0.47</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>132.48M</td>
<td>133.38M</td>
<td>126.75M</td>
<td>124.51M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>132.42M</td>
<td>130.16M</td>
<td>125.75M</td>
<td>124.69M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>CTS management provided guidance for FY 2025, expecting earnings between $2.2 and $2.35 per share.</p>
<p>To track all earnings releases for CTS <a href="https://www.benzinga.com/quote/CTS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

CTS Earnings Analysis: Q4 Recap

<p>CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 12.77 percent increase over earnings of $0.47 per share from the same period last year.  The company reported quarterly sales of $127.435 million which missed the analyst consensus estimate of $132.804 million by 4.04 percent.  This is a 2.20 percent increase over sales of $124.694 million the same period last year.</p>


Earnings Misses

CTS Q4 2024 Adj. EPS $0.53 Misses $0.59 Estimate, Sales $127.435M Miss $132.804M Estimate

ALGT

AMCR

AMGN

APAM

ARMK

ATEN

ATKR

AUDC

AVNW

AXTA

AZEK

AZPN

BALL

BERY

COLM

CRUS

CVRX

EGHT

ENVA

FICO

FLNG

FOXA

GBDC

GOOGL

HLNE

HUBB

ICHR

IESC

INGR

INMD

INNV

INTA

JKHY

JNPR

KLIC

KTCC

LANC

LARK

LUMN

MDLZ

MLAB

MPLX

MRCY

MSGS

MTCH

MUFG

OCSL

OSCR

PINC

PYPL

RACE

Earnings Scheduled For February 4, 2025

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMBC

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

Comments

CTS

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga